{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:27:27Z","timestamp":1787056047260,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>New-onset diabetes (NOD) can precede the clinical diagnosis of pancreatic ductal adenocarcinoma (PDAC) and may indicate occult or preclinical disease. However, identifying the small subgroup of patients with NOD who are at sufficiently high risk to justify further evaluation remains challenging. This systematic review and meta-analysis evaluated the performance of PDAC risk prediction models in patients with NOD and summarized their reported discriminative ability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase, and Web of Science from inception to March 16, 2026. Eligible studies developed or validated PDAC risk prediction models in patients with NOD. Risk of bias was assessed using the Prediction model Risk Of Bias Assessment Tool (PROBAST). Concordance indices (C-indices) were pooled using a random-effects model. For validation cohorts without reported variance estimates, standard errors were approximated using the Hanley-McNeil method. Subgroup analyses, meta-regression, and sensitivity analyses were performed to explore heterogeneity and assess the robustness of the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen studies comprising 17 prediction models were included, and 14 independent validation cohort estimates were available for quantitative synthesis. Most models had a high risk of bias in the analysis domain. The pooled C-index was 0.78 (95% confidence interval, 0.75-0.82), with a 95% prediction interval of 0.68-0.86 and substantial heterogeneity (I\u00b2 = 95.0%). This estimate should be interpreted as a descriptive summary of reported discrimination across heterogeneous validation cohorts rather than as a directly generalizable estimate of clinical performance. Exploratory subgroup analyses suggested higher discrimination in prospective validation cohorts and in models with 2-year prediction windows than in models with 3-year or other\/unspecified prediction windows, although several subgroups included few validation cohorts and residual heterogeneity remained substantial. Models evaluated using internal validation showed numerically higher discrimination than those evaluated using independent external validation, suggesting potential optimism. Older age, unintentional weight loss, rapid glycemic deterioration, and proton pump inhibitor use were recurrent clinical warning signals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Existing PDAC risk prediction models for patients with NOD show moderate discrimination. However, substantial heterogeneity, limited independent external validation, incomplete calibration reporting, and inconsistent assessment of clinical utility constrain their immediate clinical translation. These models should be interpreted as tools for temporal risk stratification rather than as evidence of a causal relationship between NOD and PDAC onset. Future studies should standardize NOD definitions, improve calibration and interpretability reporting, and prioritize prospective external validation and clinical impact studies before implementation in screening pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO<\/jats:ext-link>\n                      , identifier CRD420261360099.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1868121","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:32:51Z","timestamp":1787052771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance of risk prediction models for pancreatic cancer in patients with new-onset diabetes: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[{"name":"Senior Department of Oncology, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Senior Department of Oncology, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[{"name":"Senior Department of Oncology, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Tian","sequence":"additional","affiliation":[{"name":"Senior Department of Oncology, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Le","sequence":"additional","affiliation":[{"name":"Senior Department of Oncology, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Senior Department of Oncology, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70035","article-title":"Advances in pancreatic cancer early diagnosis, prevention, and treatment: the past, the present, and the future","volume":"76","author":"Mannucci","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.10232","article-title":"Screening for pancreatic cancer: US Preventive Services Task Force reaffirmation recommendation statement","volume":"322","year":"2019","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer","volume":"62","author":"Canto","year":"2013","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.06.025","article-title":"Risk of pancreatic cancer in glycemically defined new-onset diabetes: a prospective cohort study","volume":"170","author":"Chari","year":"2026","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i30.4939","article-title":"Diabetes and pancreatic cancer: exploring the two-way traffic","volume":"27","author":"Roy","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000754","article-title":"Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus","volume":"37","author":"Hart","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100155","article-title":"Early prediction of pancreatic cancer from new-onset diabetes: an AIOM\/AMD\/SIE\/SIF multidisciplinary consensus position paper","volume":"6","author":"Gallo","year":"2021","journal-title":"ESMO Open"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7798","article-title":"Potential cost-effectiveness of risk-based pancreatic cancer screening in patients with new-onset diabetes","volume":"20","author":"Schwartz","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.14309\/ajg.0000000000002022","article-title":"Clinical prediction models for pancreatic cancer in general and at-risk populations: a systematic review","volume":"118","author":"Santos","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1698850","article-title":"Risk factors and early prediction of pancreatic cancer among patients with diabetes mellitus: a systematic review and meta-analysis","volume":"16","author":"Cong","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11113040","article-title":"Accuracy of the END-PAC model in predicting the risk of developing pancreatic cancer in patients with new-onset diabetes: a systematic review and meta-analysis","volume":"11","author":"Hajibandeh","year":"2023","journal-title":"Biomedicines"},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16503","article-title":"Predicting the risk of pancreatic cancer in women with new-onset diabetes mellitus","volume":"39","author":"Ali","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1053\/j.gastro.2016.11.046","article-title":"A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes","volume":"152","author":"Boursi","year":"2017","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002000","article-title":"Validation of the enriching new-onset diabetes for pancreatic cancer model: a retrospective cohort study using real-world data","volume":"51","author":"Boursi","year":"2022","journal-title":"Pancreas"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002052","article-title":"A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes","volume":"34","author":"Boursi","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10620-020-06139-z","article-title":"Validation of the enriching new-onset diabetes for pancreatic cancer model in a diverse and integrated healthcare setting","volume":"66","author":"Chen","year":"2021","journal-title":"Dig Dis Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2023.107965","article-title":"Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters","volume":"244","author":"Cichosz","year":"2024","journal-title":"Comput Methods Programs BioMed"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02693-9","article-title":"Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model","volume":"130","author":"Clift","year":"2024","journal-title":"Br J Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S180791","article-title":"Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models","volume":"10","author":"Hsieh","year":"2018","journal-title":"Cancer Manag Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.02.001","article-title":"Validation of the ENDPAC model: identifying new-onset diabetics at risk of pancreatic cancer","volume":"21","author":"Khan","year":"2021","journal-title":"Pancreatology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001897","article-title":"Machine learning predicts patients with new-onset diabetes at risk of pancreatic cancer","volume":"58","author":"Khan","year":"2024","journal-title":"J Clin Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1053\/j.gastro.2022.01.016","article-title":"Predicting pancreatic cancer in the UK Biobank cohort using polygenic risk scores and diabetes mellitus","volume":"162","author":"Sharma","year":"2022","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70388","article-title":"Predicting pancreatic cancer in new-onset diabetes cohort using a novel model with integrated clinical and genetic indicators: a large-scale prospective cohort study","volume":"13","author":"Sun","year":"2024","journal-title":"Cancer Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12916-025-04048-4","article-title":"Combining genetic and non-genetic factors to predict the risk of pancreatic cancer in patients with new-onset diabetes mellitus","volume":"23","author":"Zhou","year":"2025","journal-title":"BMC Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"B30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210203","article-title":"Role of pancreatic tumour-derived exosomes and their cargo in pancreatic cancer-related diabetes","volume":"24","author":"Binang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-025-06543-y","article-title":"Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis","volume":"68","author":"Toledo","year":"2025","journal-title":"Diabetologia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.cmet.2023.10.003","article-title":"Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2025.06.003","article-title":"Unraveling the sweet connection between pancreatic cancer and hyperglycemia","volume":"37","author":"Post","year":"2026","journal-title":"Trends Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01376-w","article-title":"Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review","volume":"8","author":"Ruze","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116811","article-title":"PDX1 phosphorylation at S61 by mTORC1 links nutrient signaling to \u03b2 cell function and metabolic disease","volume":"45","author":"Fan","year":"2026","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151240","article-title":"Amino acids control blood glucose levels through mTOR signaling","volume":"101","author":"Fan","year":"2022","journal-title":"Eur J Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cells13090781","article-title":"Nuclear mTOR signaling orchestrates transcriptional programs underlying cellular growth and metabolism","volume":"13","author":"Zhao","year":"2024","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41421-019-0112-z","article-title":"PKAc-directed interaction and phosphorylation of Ptc is required for Hh signaling inhibition in Drosophila","volume":"5","author":"Fan","year":"2019","journal-title":"Cell Discov"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf308","article-title":"Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway\/gene-set analysis","volume":"118","author":"Zhang","year":"2026","journal-title":"J Natl Cancer Inst"},{"key":"B41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1158\/2159-8290.CD-25-0323","article-title":"Development and prospective validation of a cell-free DNA-based model for the early detection of pancreatic cancer","volume":"16","author":"Wang","year":"2026","journal-title":"Cancer Discov"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1345810","article-title":"Exploring the application and future outlook of artificial intelligence in pancreatic cancer","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-019-1426-2","article-title":"Key challenges for delivering clinical impact with artificial intelligence","volume":"17","author":"Kelly","year":"2019","journal-title":"BMC Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1868121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:32:52Z","timestamp":1787052772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1868121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":45,"alternative-id":["10.3389\/fonc.2026.1868121"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1868121","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1868121"}}